Actively Recruiting
Testing Sublingual Caffeine to Speed Up Recovery and Reduce Agitation After General Anesthesia in Patients 65 and Older Undergoing Eye Surgery
Led by Cairo University · Updated on 2026-04-21
50
Participants Needed
1
Research Sites
6 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effects of sublingual caffeine on recovery time and postoperative agitation in elderly patients undergoing general anesthesia. With an aging population, older adults face increased risks of delayed awakening and complications after surgery due to changes in how anesthesia affects their bodies. This study aims to see if caffeine, which stimulates the central nervous system, can help patients wake up faster and reduce agitation after surgery. Participants will be randomly assigned to receive either sublingual caffeine or a placebo at the end of their surgery. The caffeine acts by blocking certain receptors in the brain that promote sleep, potentially speeding recovery. This is a double-blind study, meaning neither the patients nor the researchers know who receives caffeine or placebo during the trial. During the study, researchers will measure how long it takes patients to open their eyes in response to commands and how quickly they leave the post-anesthesia care unit. They will also monitor for agitation within 30 minutes after extubation and check for any complications within 24 hours after surgery. The total participation period includes the surgery day and 24 hours of postoperative monitoring, with careful cognitive screening before surgery to ensure eligibility.
CONDITIONS
Brief Title
Sublingual Caffeine on Reducing Recovery Time and Postoperative Agitation in Elderly Patients Undergoing General Anesthesia
Research Team
G
Ghada A Sherif, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here